Santhera Pharmaceuticals Holding(SPHDF)
$18.300.00 (0.00%)
SPHDF
Santhera Pharmaceuticals Holding financials statements
$18.30
At close:0.00 (0.00%)
Santhera Pharmaceuticals Holding (SPHDF) Ratios
40 Followers
Santhera Pharmaceuticals Holding Ratios
SPHDF's free cash flow for Q2 2026 was CHF14.79M. For the 2026 fiscal year, SPHDF's free cash flow was decreased by CHF-38.00K and operating cash flow was CHF14.82M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.29 | 1.64 | 0.78 | 0.06 | 0.75 |
| Quick Ratio | 0.89 | 1.26 | 0.74 | 0.06 | 0.74 |
| Cash Ratio | 0.36 | 0.89 | 0.69 | 0.03 | 0.65 |
| Solvency Ratio | -0.27 | -0.29 | 1.16 | -0.63 | -0.58 |
| Operating Cash Flow Ratio | -0.56 | -0.77 | 1.07 | -0.60 | -1.14 |
| Short-Term Operating Cash Flow Coverage | -2.44 | -5.11 | 2.26 | -1.35 | -2.43 |
| Net Current Asset Value | CHF -79.66M | CHF -48.98M | CHF -15.03M | CHF -104.35M | CHF -65.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.66 | 0.27 | 0.21 | 0.70 | 0.47 |
| Debt-to-Equity Ratio | -8.27 | 1.49 | 0.38 | -1.02 | 32.36 |
| Debt-to-Capital Ratio | 1.14 | 0.60 | 0.28 | 59.17 | 0.97 |
| Long-Term Debt-to-Capital Ratio | 1.19 | 0.53 | 0.02 | -0.93 | 0.95 |
| Financial Leverage Ratio | -12.53 | 5.51 | 1.83 | -1.46 | 68.61 |
| Debt Service Coverage Ratio | -1.25 | -0.60 | 1.87 | -1.12 | -1.11 |
| Interest Coverage Ratio | -3.27 | -1.66 | 3.23 | -2.57 | -3.46 |
| Debt to Market Cap | 0.53 | 0.25 | 0.22 | 0.51 | 0.91 |
| Interest Debt Per Share | 8.40 | 5.39 | 4.19 | 10.61 | 17.38 |
| Net Debt to EBITDA | -2.34 | -0.02 | -0.09 | -0.92 | -0.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.74% | 58.69% | 96.87% | 51.93% | 336.18% |
| EBIT Margin | -48.99% | -55.05% | 73.62% | -674.79% | 2400.88% |
| EBITDA Margin | -41.62% | -40.62% | 76.56% | -625.97% | 2167.40% |
| Operating Profit Margin | -48.99% | -85.34% | 66.57% | -695.52% | 3566.65% |
| Pretax Profit Margin | -63.55% | -106.51% | 53.01% | -944.95% | 3430.53% |
| Net Profit Margin | -63.79% | -107.30% | 52.97% | -951.10% | 3481.25% |
| Continuous Operations Profit Margin | -63.79% | -107.30% | 52.97% | -951.10% | 3481.25% |
| Net Income Per EBT | 100.38% | 100.75% | 99.93% | 100.65% | 101.48% |
| EBT Per EBIT | 129.71% | 124.80% | 79.63% | 135.86% | 96.18% |
| Return on Assets (ROA) | -33.25% | -27.53% | 49.97% | -111.53% | -60.94% |
| Return on Equity (ROE) | 416.69% | -151.54% | 91.39% | 162.70% | -4181.17% |
| Return on Capital Employed (ROCE) | -44.02% | -31.39% | 105.40% | -363.16% | -97.52% |
| Return on Invested Capital (ROIC) | -37.53% | -29.32% | 79.23% | -140.24% | -76.55% |
| Return on Tangible Assets | -58.51% | -50.24% | 153.61% | -1572.48% | -209.37% |
| Earnings Yield | -30.02% | -26.70% | 52.79% | -84.53% | -122.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.96 | 2.82 | 235.03 | 6.85 | -0.82 |
| Payables Turnover | 4.62 | 1.68 | 0.91 | 0.92 | 1.56 |
| Inventory Turnover | 2.52 | 0.89 | 1.79 | 33.26 | 8.80 |
| Fixed Asset Turnover | 38.40 | 15.21 | 177.69 | 7.41 | -1.20 |
| Asset Turnover | 0.52 | 0.26 | 0.94 | 0.12 | -0.02 |
| Working Capital Turnover Ratio | 3.23 | 3.91 | -3.69 | -0.27 | 0.16 |
| Cash Conversion Cycle | 188.81 | 324.65 | -195.33 | -331.53 | -635.27 |
| Days of Sales Outstanding | 123.13 | 129.56 | 1.55 | 53.29 | -443.03 |
| Days of Inventory Outstanding | 144.72 | 411.83 | 204.33 | 10.97 | 41.47 |
| Days of Payables Outstanding | 79.05 | 216.73 | 401.22 | 395.79 | 233.71 |
| Operating Cycle | 267.85 | 541.39 | 205.89 | 64.26 | -401.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.67 | -3.12 | 4.47 | -4.90 | -10.93 |
| Free Cash Flow Per Share | -2.68 | -3.14 | 2.22 | -5.55 | -10.94 |
| Dividend Paid and CapEx Coverage Ratio | -668.52 | -235.28 | 1.99 | -7.54 | -2490.60 |
| Capital Expenditure Coverage Ratio | -668.52 | -235.28 | 1.99 | -7.54 | -2490.60 |
| Operating Cash Flow Coverage Ratio | -0.36 | -0.86 | 2.05 | -0.67 | -0.87 |
| Operating Cash Flow to Sales Ratio | -0.45 | -0.91 | 0.46 | -3.99 | 23.42 |
| Free Cash Flow Yield | -21.23% | -22.70% | 22.67% | -40.20% | -82.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.33 | -3.75 | 1.89 | -1.18 | -0.82 |
| Price-to-Sales (P/S) Ratio | 2.12 | 4.02 | 1.00 | 11.25 | -28.49 |
| Price-to-Book (P/B) Ratio | -13.88 | 5.68 | 1.73 | -1.92 | 34.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.71 | -4.41 | 4.41 | -2.49 | -1.22 |
| Price-to-Operating Cash Flow Ratio | -4.72 | -4.42 | 2.20 | -2.82 | -1.22 |
| Price-to-Earnings Growth (PEG) Ratio | -1.37 | 0.02 | -0.01 | 0.04 | 0.01 |
| Enterprise Value Multiple | -7.45 | -9.91 | 1.22 | -2.72 | -1.94 |
| Enterprise Value | 239.31M | 157.45M | 96.43M | 127.16M | 67.21M |
| EV to EBITDA | -7.45 | -9.91 | 1.22 | -2.72 | -1.94 |
| EV to Sales | 3.10 | 4.03 | 0.93 | 17.02 | -42.14 |
| EV to Free Cash Flow | -6.87 | -4.41 | 4.10 | -3.76 | -1.80 |
| EV to Operating Cash Flow | -6.88 | -4.43 | 2.04 | -4.26 | -1.80 |
| Tangible Book Value Per Share | -5.82 | -3.63 | -1.33 | -16.89 | -18.52 |
| Shareholders’ Equity Per Share | -0.91 | 2.43 | 5.67 | -7.17 | 0.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Revenue Per Share | 5.93 | 3.44 | 9.78 | 1.23 | -0.47 |
| Net Income Per Share | -3.78 | -3.69 | 5.18 | -11.67 | -16.25 |
| Tax Burden | 1.00 | 1.01 | 1.00 | 1.01 | 1.01 |
| Interest Burden | 1.30 | 1.93 | 0.72 | 1.40 | 1.43 |
| Research & Development to Revenue | 0.29 | 0.68 | 0.18 | 4.09 | -18.63 |
| SG&A to Revenue | 0.40 | 0.76 | 0.20 | 1.95 | -7.98 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.06 | 0.73 | -1.73 |
| Income Quality | 0.71 | 0.85 | 0.86 | 0.42 | 0.68 |
Currency in CHF
